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Abstract
Using specific riboprobes, we characterized the expression of VGLUT1-VGLUT3 transcripts in
lumbar 4-5 (L4-5) DRGs and the thoracolumbar to lumbosacral spinal cord in male BALB/C mice
after a 1- or 3-day hindpaw inflammation, or a 7-day sciatic nerve axotomy. Sham animals were
also included. In sham and contralateral L4-5 DRGs of injured mice, VGLUT1-, VGLUT2- and
VGLUT3 mRNAs were expressed in ~45%, ~69% or ~17% of neuron profiles (NPs), respectively.
VGLUT1 was expressed in large and medium-sized NPs, VGLUT2 in NPs of all sizes, and
VGLUT3 in small and medium-sized NPs. In the spinal cord, VGLUT1 was restricted to a number
of NPs at thoracolumbar and lumbar segments, in what appears to be the dorsal nucleus of Clarke,
and in mid laminae III-IV. In contrast, VGLUT2 was present in numerous NPs at all analyzed
spinal segments, except the lateral aspects of the ventral horns, especially at the lumbar
enlargement, where it was virtually absent. VGLUT3 was detected in a discrete number of NPs in
laminae III-IV of the dorsal horn. Axotomy resulted in a moderate decrease in the number of DRG
NPs expressing VGLUT3, whereas VGLUT1 and VGLUT2 were unaffected. Likewise, the
percentage of NPs expressing VGLUT transcripts remained unaltered after hindpaw inflammation,
both in DRGs and the spinal cord. Altogether, these results confirm previous descriptions on
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VGLUTs expression in adult mice DRGs, with the exception of VGLUT1, whose protein
expression was detected in a lower percentage of mouse DRG NPs. A detailed account on the
location of neurons expressing VGLUTs transcripts in the adult mouse spinal cord is also
presented. Finally, the lack of change in the number of neurons expressing VGLUT1 and VGLUT2
transcripts after axotomy, as compared to data on protein expression, suggests translational rather
than transcriptional regulation of VGLUTs after injury.
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Glutamate has an essential role in sensory neuron signaling, and it also participates in both
acute and chronic pain mechanisms (Chiosa and Gane, 1956; Curtis et al., 1960; Karim et
al., 2001; Minami et al., 2001; Sung et al., 2003; Binns et al., 2005; Liaw et al., 2005; Tao et
al., 2005; Moechars et al., 2006). Presence of glutamate in dorsal root ganglion (DRG)
neurons and their projections was first identified by Rustioni and Weinberg (1989).
Recently, vesicular glutamate transporters (VGLUTs), the proteins responsible for the
uptake of glutamate into synaptic vesicles, have been identified and characterized in
numerous neuron types in both the central (CNS) and peripheral nervous systems (PNS) (see
Kaneko and Fujiyama, 2002; Fremeau, Jr. et al., 2004; Seal and Edwards, 2006; Takamori,
2006). Because their expression is directly related to the glutamatergic phenotype of
neurons, VGLUTs have emerged as the definitive markers to histochemically identify
neurons that use glutamate as a neurotransmitter (see Brumovsky et al., 2011a and
references therein). Three subtypes have been described thus far, VGLUT1, (Ni et al., 1994;
Bellocchio et al., 2000; Takamori et al., 2000), VGLUT2 (Aihara et al., 2000; Fremeau, Jr.
et al., 2001; Takamori et al., 2001; Bai et al., 2001; Hayashi et al., 2001; Herzog et al., 2001;
Sakata-Haga et al., 2001; Varoqui et al., 2002) and VGLUT3 (Fremeau, Jr. et al., 2002; Gras
et al., 2002; Schäfer et al., 2002).
Rodent DRG neurons are divided between those that innervate visceral and non-visceral
tissues (see Robinson and Gebhart, 2008 and references therein). Initial studies focused on
the immunohistochemical expression of VGLUT1 and VGLUT2 in rat DRG neurons
projecting to non-visceral tissues (lumbar (L) 4 and 5), showing that VGLUT1 was primarily
expressed in large non-peptidergic neurons whereas VGLUT2 was expressed in neurons of
all sizes, including peptidergic ones (Tong et al., 2001; Oliveira et al., 2003; Hwang et al.,
2004). These observations found a correlate in mouse (Brumovsky et al., 2007; Scherrer et
al., 2010) and guinea pig (Morris et al., 2005) DRG neurons, as well as those targeting
visceral organs such as the colorectum (Brumovsky et al., 2011a) or the urinary bladder
(Brumovsky et al., 2012). The identification of VGLUT3 in DRGs has been more difficult,
mainly because none of the commercially available antibodies against VGLUT3 efficiently
labels these neurons or their projections. However, the recent generation of transgenic mice
where reporter proteins such as the enhanced green fluorescent protein (EGFP) are under
control of the VGLUT3 promoter (VGLUT3-EGFP), demonstrated the presence of VGLUT3
in subpopulations of sciatic nerve- (Seal et al., 2009; Lou et al., 2013) and urinary bladder-
projecting (Brumovsky et al., 2012) DRG neurons.
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VGLUTs are also immunohistochemically detected in the neuropil (but not in cell bodies) of
the rodent spinal cord and exhibit different patterns of distribution, including dorsal vs.
ventral or lateral horns (Varoqui et al., 2002; Oliveira et al., 2003; Todd et al., 2003; Olave
and Maxwell, 2003; Li et al., 2003a; Alvarez et al., 2004; Hwang et al., 2004; Landry et al.,
2004; Morris et al., 2005; Persson et al., 2006; Llewellyn-Smith et al., 2007; Seal et al.,
2009). Some of the immunoreactivity to VGLUTs in the spinal cord represents transporter
molecules synthesized in DRG neurons and then axonally transported through the central
branches of dorsal roots to the spinal cord. This was first suggested by Varoqui et al. (2002),
and later demonstrated by Todd et al. (2003), showing that VGLUT1 and VGLUT2 proteins
are present in transganglionically labeled primary afferent terminals in the dorsal horn of the
spinal cord of rat. In support, dorsal rhizotomy, a procedure normally utilized to unveil the
contribution of molecules produced by DRG neurons and actively transported to the spinal
cord, results in a dramatic (although not complete) decrease in VGLUT1-like-
immunoreactivity (Li) in nerve fibers in the ventral and to some extent also in the dorsal
horn of rats (Oliveira et al., 2003; Li et al., 2003a; Alvarez et al., 2004) and mice
(Brumovsky et al., 2007). A decrease, although restricted to the superficial laminae of the
dorsal horn, has been described for VGLUT3 as well as for VGLUT3-EGFP in transgenic
mice (Seal et al., 2009). In contrast, and with one exception in the rat showing an ipsilateral
decrease (Li et al., 2003a), dorsal rhizotomy fails to alter the immunoreactivity of VGLUT2,
both in rat (Oliveira et al., 2003; Alvarez et al., 2004) and mouse (Brumovsky et al., 2007).
These observations suggest presence of more than one source VGLUT proteins detected in
the spinal cord. In fact, brainstem- (Oliveira et al., 2003; Du et al., 2012) and cortical-
derived (Fremeau, Jr. et al., 2001; Persson et al., 2006; Du et al., 2012) descending fibers
express VGLUT1 and/or VGLUT2.
Analyses of VGLUT transcripts in DRGs and spinal cord also have received attention. Thus,
the use of oligo- (Oliveira et al., 2003) and riboprobes (Landry et al., 2004) in the adult rat
revealed that VGLUT1 (Oliveira et al., 2003; Landry et al., 2004) and VGLUT2 (Landry et
al., 2004) transcripts are expressed by a considerable number of neurons in L4-5 DRGs.
VGLUT3 mRNA was also identified in rat DRGs by means of RT-PCR (Gras et al., 2002).
More recently, the presence of VGLUT3 transcripts has been reported (but not quantified) in
neonatal mouse DRG neurons (Lou et al., 2013). In the spinal cord, neuronal expression for
all VGLUTs has been described in adult rats (Oliveira et al., 2003; Landry et al., 2004;
Llewellyn-Smith et al., 2007), neonatal rats (Kullander et al., 2003), as well as in neonatal
mice (Lou et al., 2013). However, the pattern of distribution for each VGLUT differs among
studies (Oliveira et al., 2003; Kullander et al., 2003; Landry et al., 2004; Llewellyn-Smith et
al., 2007; Lou et al., 2013).
To date, neither a detailed description of the transcript expression of VGLUTs in mouse
DRG and spinal cord neurons is available, nor knowledge of possible changes in expression
after peripheral nerve injury or inflammation. Thus, in the present study, we have
characterized the expression of the three VGLUTs in lumbar DRG neurons and the
thoracolumbar, lumbar and lumbosacral spinal cord of BALB/c mice by means of in situ
hybridization. We used selective riboprobes that have been validated in their specificity to
identify VGLUTs in peripheral neurons (Brumovsky et al., 2011a). Animals with a 1- or 3-
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day hindpaw inflammation or a 7-day axotomy of the sciatic nerve were included in the
analysis. Portions of these data have been reported in abstract form (Vieytes et al., 2013).
EXPERIMENTAL PROCEDURES
Animals
The experiments were performed on fifty-one male BALB/C mice (b.wt. 20-30 g). The
animals were maintained under standard conditions on a 12-hour day/night cycle (light on at
7AM), with water and food ad libitum. All experiments were performed following the
Society for Neuroscience and the International Association for the Study of Pain guidelines
for the use of animals in research, and approved by the institutional ethics committees
(University of Pittsburgh and Austral University).
Axotomy (Axo)
Under aseptic conditions, mice were anesthetized with Isoflurane (Hospira Inc., Lake Forest,
IL), and a complete transection of the right sciatic nerve was performed. Briefly, the right
sciatic nerve was exposed mid-thigh and a 5- to 8-mm-long segment dissected free from the
surrounding tissue, strongly ligated and transected distal to the ligation. In all cases, a 5-mm-
long segment was resected distal to the transection. Finally, muscles and skin were sutured
in layers, the skin incision treated with dibucaine ointment (1%, Perrigo, Allegan, MI), and
subcutaneous buprenorphine (0.1 mg/kg, Bedford Labs, Bedford, OH) given for
postoperative analgesia. Mice were allowed to recover in a warm environment under close
observation.
Sham mice were treated in the same way as described above, with the exception that the
sciatic nerve was only exposed and dissected free from the surrounding connective tissue,
but it was not transected.
Hindpaw inflammation (CFA)
Lightly anesthetized mice (Isoflurane) received an injection of ~20 μl of a 1:1 solution of
Complete Freunds Adjuvant in saline (CFA; Sigma, St. Louis, MO) into the plantar surface
of the left hindpaw, using a 1-ml syringe and a 27G needle. Animals recovered in a warm
environment, and were allowed to survive for 24 or 72 hours before sacrifice (1- or 3-day
CFA, respectively). Sham animals (n = 16) received an injection of ~20 μl of saline solution.
Riboprobe in situ hybridization
Male, 7-week old, BALB/c mice were used for in situ hybridization analyses (VGLUT1 and
VGLUT2, Axo = 4, Sham-Axo = 4; 1-day CFA = 3, 1-day Sham-CFA = 3; 3-day CFA= 4,
3-day Sham-CFA= 3; VGLUT3: Axo = 5, Sham-Axo = 5; 1-day CFA = 5, 1-day Sham-CFA
= 5; 3-day CFA= 5, 3-day Sham-CFA= 5). Seven days after Axo and 1 or 3 days after
hindpaw inflammation, mice were sedated using CO2 before rapid decapitation. Contra- and
ipsilateral L4 and L5 DRGs and the thoracolumbar (TL), lumbar (L) and lumbosacral (LS)
segments of the spinal cord were quickly dissected, embedded in O.C.T. (Tissue-Tek,
Sakura, Torrance, CA) and frozen over dry ice. Sections of DRGs and the spinal cord were
cut in a cryostat (14- or 20-μm thickness, respectively), thaw-mounted onto Superfrost Plus
MALET et al. Page 4













(Fisher Scientific, Waltham, MA) glass slides and stored at −20°C until hybridization.
Adjacent sections through the different tissues were processed for in situ hybridization for
the localization of VGLUT1, VGLUT2 and VGLUT3 mRNAs. In all cases 35S-labeled
cRNA probes were used as previously described in detail (Seroogy and Herman, 1997;
Brumovsky et al., 2011a; Brumovsky et al., 2011b; Hemmerle et al., 2012).
Sense and antisense cRNA probes complementary to the coding region of mouse VGLUT1
(nucleotides 855–1788; GenBank accession number XM_133432.2), VGLUT2 (nucleotides
848–2044; GenBank accession number NM_080853.2) (Nakamura et al., 2007) and
VGLUT3 (nucleotides 1511-1768; GenBank accession numbers BB650431 and BB396899;
Schäffer et al., 2002) were prepared by in vitro transcription, after linearization of cDNA
constructs, using proper RNA polymerases (T3, T7, or SP6) and 35S-UTP (PerkinElmer,
Chelton, CT). After drying and fixation, sections were incubated for 18–24 hours at 60°C in
hybridization cocktail containing the 35S-labeled cRNA probe at a concentration of 1.0 ×
106 cpm/50 μl per slide (Seroogy and Herman, 1997; Brumovsky et al., 2011a; Brumovsky
et al., 2011b; Hemmerle et al., 2012).
For posthybridization treatment, sections were washed several times in 4 x SSC (1x SSC ¼
0.015 M sodium citrate, 0.15 M sodium chloride at pH 7.0) containing 10 mM sodium
thiosulfate at 37°C. The sections were then incubated in ribonuclease A (0.05 mg/mL) for 30
minutes at 45°C. This was followed by several washes in decreasing concentrations of SSC
(2x, 0.5x, and 0.1x) at 37°C. All but the final wash also contained 10 mM sodium
thiosulfate. After posthybridization, a brief rinse in distilled water (dH2O), a dip in 95%
ethanol, and air-drying, sections were dipped in NTB nuclear track emulsion (Kodak,
Rochester, NY; 1:1 in dH2O), air-dried, and exposed in sealed slide boxes at 4°C. Sections
hybridized with the VGLUT1 or VGLUT2 riboprobes were exposed for 5-7 days, whereas
those hybridized with the VGLUT3 riboprobe were exposed for 3-5 weeks (DRGs and the
spinal cord). D19 (Kodak) and Rapidfix (Kodak) were used for developing and fixation of
the dipped slides, respectively. Finally, all sections were counterstained with cresyl violet
(Sigma) and coverslipped with DPX mounting solution (Fluka, Buchs, Switzerland)
(Seroogy and Herman, 1997; Brumovsky et al., 2011a; Brumovsky et al., 2011b; Hemmerle
et al., 2012).
Specificity controls included the pretreatment of some sections with ribonuclease A (0.05
mg/ml) for 30 minutes at 45°C before hybridization with the 35S-labeled cRNA probes;
hybridization using sense-strand 35S-labeled riboprobes against each VGLUT; and
incubation of several tissue sections in hybridization cocktail that lacked the radioactive
probe as a chemography control. No specific labeling was observed under any of these
conditions (Seroogy and Herman, 1997; Brumovsky et al., 2011a; Brumovsky et al., 2011b;
Hemmerle et al., 2012).
Microscopy and image processing
All sections were examined with a Nikon Eclipse E800 microscope equipped with
appropriate objectives and filters for bright- and dark-field visualization, and a DS U2 Nikon
Digital Camera (Nikon, Tokyo, Japan).
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Resolution, brightness and contrast of the images were optimized using the Adobe
Photoshop CS3 software (Adobe System Inc., San Jose, CA).
Quantification and statistical analysis
Quantification was performed on L4-5 DRGs processed by in situ hybridization, in sham, 7-
day Axo, 1- or 3-day CFA mice, comparing contra- and ipsilateral sides. Every fourth DRG
section was used to quantify the number of VGLUT1-, VGLUT2- or VGLUT3 mRNA-
positive neuron profiles (NPs), as well as the total number of cresyl violet-stained NPs. In
total, between 9 and 13 sections per DRG were used for quantification. Only nucleated NPs
with a density of accumulation of silver grains 5 times greater than background were
counted as positively labeled NPs. Percentages of VGLUT-expressing NPs were obtained by
counting, within the total number of cresyl violet-stained NPs, those expressing VGLUT1-3.
Because of the quantification method utilized in this study, it is possible large diameter NPs
were overestimated, and small NPs suffered a reduction in the opportunity to be counted
(Guillery, 2002). In such case, and in particular for VGLUT2 and VGLUT3 mRNA-
expressing DRG NPs, it is possible that the percentages presented here were underestimated.
However, the intention of this study is only to provide with estimated numbers of the
expression of each VGLUTs, and their differential distributions in DRG NPs. Establishing
the absolute number of DRG neurons expressing each VGLUT in this study would require
neurostereology (Mayhew and Gundersen, 1996), a method that is not easily applied to
sections processed by in situ hybridization methods.
For the evaluation of neuronal size distribution, the cell body diameters of a representative
sample of nucleated NPs expressing each VGLUT (VGLUT1, 1842 cells; VGLUT2, 2945
cells; VGLUT3, 2205 cells) in contralateral DRGs of all sham mice were measured using the
public domain NIH program ImageJ (developed at the U.S. National Institutes of Health and
available on the Internet at http://rsb.info.nih.gov/nih-image/). All values, separated by each
VGLUT type, were pooled into an histogram, and the NP size distribution was categorized
as follows (Brumovsky et al., 2007): 1) small, <400 μm2; 2) medium, 400-1225 μm2; and 3)
large, >1225 μm2.
Data are presented as mean ± SEM and were statistically analyzed using one-way ANOVA,
followed by the posthoc Tukey’s Multiple Comparison Test; P < 0.05 was considered
significant. Mean and median size of DRG neurons expressing each VGLUT was also
presented for comparison.
RESULTS
VGLUT1-3 mRNA expression in DRG NPs
Presence of the transcript for each VGLUT was detected in uninjured DRG NPs, albeit
showing different proportions. Thus, when taking into account the global expression of each
VGLUT in contralateral L4-5 DRGs of sham mice, VGLUT1 transcript was expressed in
~44.7 ± 4.2%, VGLUT2 transcript was present in ~69.1 ± 3.7% NPs, and VGLUT3 mRNA
was detected in ~17.1 ± 0.7% NPs (Table 1; Figure 1A, D, G). Most NPs expressing
VGLUT1 mRNA were medium-sized and large, ranging from 247 to over 2469 μm2, with an
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mean size of 987 μm2 and a median size of 952 μm2; a large proportion of these NPs were
counted between 500 and 1200 μm2 (Figs. 1B; 2A). NPs expressing VGLUT2 mRNA
showed a widespread distribution, ranging from 54 to 2810 μm2 and with an mean size of
665 μm2 and a median size of 602 μm2; most NPs were counted between 200 and 1100 μm2
(Figs. 1E, 2B). Finally, VGLUT3 mRNA was detected in small and medium-sized NPs,
ranging from 64 to 1811 μm2 and with an mean size of 459 μm2 and a median size of 433
μm2; the majority of NPs were counted between 200 and 600 μm2 (Figures 1F; 2C).
Incubation with the sense sequence of each VGLUT resulted in no specific hybridization for
VGLUT1 (Figure 1C), VGLUT2 (Figure 1F) or VGLUT3 (Figure 1I).
VGLUT1-3 mRNA expression in spinal cord
Presence of VGLUT1 mRNA was restricted to two locations in the analyzed segments of the
spinal cord. In the thoracolumbar segment, a small population of VGLUT 1 mRNA-positive
NPs was present almost exclusively in the dorsomedial part of the so-called intermediate
zone of the dorsal horn (laminae IV-V) (Figure 3A). In addition, isolated VGLUT1 mRNA-
positive NPs were detected in deep layers of the dorsal horn (laminae III-IV), at lumbar (Fig.
3B) or thoracolumbar (Fig. 4A-C) segments. In contrast, no VGLUT1 mRNA-positive NPs
were observed in lumbosacral segments (Figure 3C).
Numerous VGLUT2 mRNA-positive NPs were observed at all analyzed segments of the
spinal cord. In the dorsal horn, neurons distinctly expressing VGLUT2 mRNA were detected
in lamina I and deeper laminae (III-VI) (Figs. 3E-G; 5A-C). In contrast, laminae II-III
exhibited a more diffuse VGLUT2 mRNA hybridization signal (Figs. 3E-G; 5A), virtually
always corresponding to neuronal profiles (Fig. 5B, C). In area X and the medial aspects of
the ventral horns, many VGLUT2 mRNA-positive neurons were detected (Figs. 3E-G; 5A,
D, E). However, especially at the lumbar enlargement, the lateral aspects of the ventral
horns appeared devoid of VGLUT2 mRNA-labeled neurons (Figs. 3F; 5A, E).
A small number of weakly labeled VGLUT3 mRNA-positive neurons were detected in
thoracolumbar, lumbar and lumbosacral segments of the dorsal horn, mostly in laminae III-
IV (Figs. 3I, K; 6A, B).
In all cases in the spinal cord, incubation with each corresponding sense VGLUT riboprobe
revealed no specific hybridization signal (Fig. 3D, H, L).
Effects of Axotomy and 1- or 3-day hindpaw inflammation
Whereas the number of VGLUT1 (Fig. 7A, B) and VGLUT2 (Fig. 7C, D) mRNA-positive
L4-5 DRG NPs remained unaltered after axotomy of the sciatic nerve (Table 1), a discrete
but significant reduction in the number of VGLUT3 mRNA-positive NPs was observed
(one-way ANOVA, P=0.0334; 12.8 ± 0.4% ipsilateral AXO vs. 17.8 ± 1.6% contralateral
AXO, Tukey’s, P<0.05; Table 1; Fig. 7E, F).
No obvious changes were observed in the percentage of VGLUT1- or VGLUT2 mRNA-
positive L4-5 DRG NPs after 1- or 3-day hindpaw inflammation (Table 1). The same
outcome was obtained with VGLUT3, although one-way ANOVA analysis of the percentage
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of VGLUT3 mRNA-expressing NPs after 1-day hindpaw inflammation resulted in a small
statistical significance (P=0.0491), that was, however, not supported by posthoc analysis
between groups. Likewise, none of the injuries resulted in evident changes in the number of
NPs expressing any of the VGLUT mRNAs at the spinal cord level (data not shown).
DISCUSSION
In this study, we present a thorough analysis of the presence of VGLUT1-3 transcripts in
L4-5 DRGs and spinal cord NPs of mouse, including the effects of axotomy of the sciatic
nerve or hindpaw inflammation. We show: 1) presence of VGLUT1, VGLUT2 and VGLUT3
transcripts in different proportions of DRG NPs and with different size distributions, with
VGLUT2 being the most abundant transporter; 2) a larger percentage of VGLUT1 mRNA-
positive DRG NPs than previously reported in mouse for its corresponding protein
(Brumovsky et al., 2007); 3) presence of all VGLUTs in the spinal cord, with VGLUT2
being most abundantly expressed, followed by VGLUT1, almost exclusively in NPs that
likely belong to the dorsal nucleus of Clarke, and finally VGLUT3, weakly detected in some
NPs in the deep dorsal horn, and in accordance with a recent study in neonatal mice (Lou et
al., 2013); 4) a small but significant decrease in the percentage of DRG NPs expressing the
VGLUT3 transcript after sciatic nerve axotomy; VGLUT1 and VGLUT2 transcripts
remained unaltered; 5) lack of any detectable change in the number of neurons expressing
any VGLUTs transcript after hindpaw inflammation.
VGLUT transcript expression in mouse DRGs
In the first in situ hybridization analysis of the expression of VGLUT1 in rat L4-5 DRGs,
Oliveira et al. (2003) reported that “…Many DRG neurons were VGLUT1 mRNA positive,
and they were primarily large…”, although no quantification was performed at that time. In
the rat trigeminal ganglia, ~80% of VGLUT1-immunoreactive (IR) neurons were detected
(Li et al., 2003b), and Landry et al. (Landry et al., 2004) reported that most L4-5 DRG
neurons in the rat expressed VGLUT1 transcript. A few years later, Morris et al. (2005)
reported in mouse L4-5 DRGs up to 37% of VGLUT1-IR neurons, a proportion comparable
to the ~32% VGLUT1-IR neurons projecting to the mouse urinary bladder (Brumovsky et
al., 2012). In the present study in mouse, we show that ~45% of L4-5 DRG neurons of large
and medium size express VGLUT1 mRNA. However, in other immunohistochemical studies
in mouse, only up to ~11% L4-5 DRG neurons expressing VGLUT1 (Brumovsky et al.,
2007) were detected, similar to the percentage of DRG neurons projecting to the colorectum
(~12%; Brumovsky et al., 2011a). Differences in the number of neurons expressing the
VGLUT1 protein between DRG levels could result from differential protein and gene
regulation at each level. More difficult to explain are the differences in protein and transcript
expressions across studies, although they could relate to the use of various types of VGLUT1
antibodies/probes, immunohistochemical and in situ hybridization techniques or even mouse
strains. Alternatively, it could also be speculated that not all VGLUT1 transcript is translated
into protein, suggesting different regulatory mechanisms.
In the present study, we found that the VGLUT2 mRNA is expressed by ~69% of mouse
L4-5 DRG neurons, consistent with the percentages obtained in a recent study (~82%;
MALET et al. Page 8













Scherrer et al., 2010). In accordance, in a previous study in mouse we found that VGLUT2
protein is present in ~65% of L4-5 DRG neurons (Brumovsky et al., 2007). An even more
abundant presence of VGLUT2-expressing NPs has also been show in mouse DRG (~90%;
Scherrer et al., 2010) and rat trigeminal ganglia (~80%; Li et al., 2003b), and in mouse
visceral DRG neurons, where more than 90% and up to 98% of urinary bladder-
(Brumovsky et al., 2012) or colorectum-projecting (Brumovsky et al., 2011a) NPs express
VGLUT2, respectively. VGLUT2-expressing DRG neurons span all cell soma sizes,
although many of them are small and medium-sized (Brumovsky et al., 2007; 2011a; 2012;
present study). Altogether, the abundance of VGLUT2 in a variety of peripheral sensory
neurons supports the hypothesis that this is the main VGLUT in DRG neurons, and of its
likely importance for glutamatergic neurotransmission.
We detected VGLUT3 transcript in ~17% of mouse L4-5 DRG NPs. This small percentage
is in agreement with studies using transgenic mice (Seal et al., 2009; Lou et al., 2013). Thus,
Seal et al. (2009) showed that 10-11% of L4-5 DRG or trigeminal ganglion neurons in the
mouse express VGLUT3-EGFP. In a more recent study, using the reporter gene Tomato,
~19% of adult mouse L4-5 DRG neurons of small size were shown to express VGLUT3
(Lou et al., 2013). Interestingly, these authors also showed a transient vs. persistent
expression of VGLUT3. Thus, the transporter was found in large and medium-sized
myelinated DRG neurons during prenatal stages, it was downregulated during neonatal
stages, and only the small neuron population remained VGLUT3-expressing during the adult
life (Lou et al., 2013). Here, we not only detected VGLUT3 mRNA in small but also in
medium-sized DRG NPs. It remains to be established whether the latter reflect some degree
of persistence in the expression of the VGLUT3 (transcript and/or protein) from prenatal
stages. Finally, visceral DRGs projecting to the mouse colorectum (Brumovsky et al.,
2011a) or urinary bladder (Brumovsky et al., 2012) also present with low percentages of
VGLUT3-expressing small DRG neurons (~10% and ~18%, respectively).
The abundance of VGLUT2 over the other two VGLUTs implies a certain degree of
coexistence, a concept that was originally rejected (Fremeau, Jr. et al., 2001; Kaneko and
Fujiyama, 2002; Schäfer et al., 2002), but is slowly gaining acceptance, for neurons both in
the central (Boulland et al., 2004; Herzog et al., 2006) as well as the peripheral nervous
systems (Li et al., 2003b; Landry et al., 2004; Brumovsky et al., 2007). In fact, coexistence
of VGLUT1 and VGLUT2-Lis has been shown in rat trigeminal ganglion neurons (Li et al.,
2003b), and in rat (Landry et al., 2004) or mouse L4-5 DRG neurons (Brumovsky et al.,
2007); preliminary results in our laboratory also indicate that VGLUT2 and VGLUT3 largely
coexpress in L4-5 DRGs (unpublished results). Moreover, the overwhelming expression of
VGLUT2 in colorectal (Brumovsky et al., 2011a) and urinary bladder (Brumovsky et al.,
2012) DRG neurons observed in mouse strongly supports coexpression with other VGLUTs
in visceral neurons. In conclusion, DRG neurons may be provided with at least two different
VGLUTs, although subpopulations expressing only one type of VGLUT are also likely.
It has been suggested that VGLUT expression may be associated with different patterns of
neurotransmitter release. Thus, VGLUT1 is normally expressed in CNS neurons with low
probability release (climbing fibers in the cerebellum), whereas VGLUT2 would be
associated to those with high probability (parallel fibers in the cerebellum) (Dittman and
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Regehr, 1998). To what extent the type of VGLUT can be associated with release
probability also in DRG neurons will require further research. An interesting question, then,
is also the significance of the presence of more than one VGLUT in DRG neurons for
glutamate release.
VGLUT transcript expression in mouse spinal cord
In the present study in adult mouse, neurons expressing different VGLUT transcripts were
detected in the spinal cord, confirming previous studies in rat (Oliveira et al., 2003; Landry
et al., 2004; Llewellyn-Smith et al., 2007) and neonatal mouse (Kullander et al., 2003; Lou
et al., 2013). Each VGLUT exhibited a differential distribution across the analyzed laminae
and spinal segments. VGLUT1 was almost exclusively detected in the thoracolumbar spinal
cord, in a subpopulation of neurons located in the dorsomedial part of the intermediate zone
of the dorsal horn (laminae IV-V). Interestingly, this area is known to contain the dorsal
nucleus of Clarke, the origin of the spinocerebellar pathways (Mann, 1973). Additional
isolated VGLUT1 mRNA-positive neurons were also found in the medial aspects of the deep
dorsal horn (laminae III-IV). Other neurons, including motoneurons or superficial dorsal
horn neurons appeared to lack VGLUT1, in contrast to observations in rat, where VGLUT1
mRNA positive neurons are also reported in lamina I of the dorsal horn, as well as in what
appear to be motoneurons (Landry et al., 2004). Differences in the type of rodent, in situ
hybridization techniques or riboprobes may explain the discrepancy.
In addition to its presence in spinal neurons, an abundant and dorsal rhizotomy-susceptible,
VGLUT1-IR neuropil is found both in the ventral and dorsal horns (Oliveira et al., 2003;
Alvarez et al., 2004; Hughes et al., 2004; Brumovsky et al., 2007; Llewellyn-Smith et al.,
2007). A great proportion of these fibers is contributed by large and medium-sized
VGLUT1-expressing DRG neurons, and have been ascribed roles in proprioception and the
regulation of motor function (Oliveira et al., 2003; Todd et al., 2003; Kullander et al., 2003;
Alvarez et al., 2004; Landry et al., 2004; Brumovsky et al., 2007; Llewellyn-Smith et al.,
2007). Compelling evidence for a role in proprioception is the identification of numerous
fibers in the ventral horn exhibiting VGLUT1-Li and colocalizing with parvalbumin, a
marker of muscle proprioceptors, and known to participate in primary afferent-motoneuron
contacts (see Alvarez et al., 2004; Hughes et al., 2004). It should be noted, however, that
pyramidal cells in the neocortex express VGLUT1 mRNA (Fremeau, Jr. et al., 2001) and
numerous rat corticospinal tract nerve fibers terminating in the ventral horns exhibit
VGLUT1-Li (Persson et al., 2006; Du et al., 2012), thus implying the participation of
glutamate not only in proprioception (primary afferent input), but also in the supraspinal,
cortical control of motoneurons.
VGLUT1-Li is also detected in low-threshold cutaneous and muscle mechanoreceptors
terminating in the superficial and deep dorsal horn (Todd et al., 2003; Alvarez et al., 2004;
Hughes et al., 2004). Interestingly, abundant VGLUT1-IR primary afferent fibers appear to
terminate in the area occupied by Clarke’s nucleus (Oliveira et al., 2003; Alvarez et al.,
2004; Brumovsky et al., 2007), which contains the second order neurons that give rise to the
spinocerebellar pathway (Mann, 1973). If these fibers did in fact establish synaptic contact
with Clarke’s neurons, it could be hypothesized that they belong to the propriocetive
MALET et al. Page 10













spinocerebellar pathway and that it altogether utilizes VGLUT1 and glutamate for the
transmission of proprioceptive information to the cerebellum. In support, abundant
VGLUT1-Li is detected in nerve fibers terminating in the anterior and posterior zones of the
cerebellum (Gebre et al., 2012), known to receive input from spinocerebellar mossy fibers
(see Sillitoe et al., 2010).
In contrast to VGLUT1, VGLUT2 exhibited a widespread expression, being detected not
only in almost all laminae of the dorsal and ventral horns, but also across all analyzed spinal
segments (thoracolumbar to lumbosacral). Our data confirm previous studies in rat (Oliveira
et al., 2003; Todd et al., 2003; Llewellyn-Smith et al., 2007) and neonatal mouse (Kullander
et al., 2003) on the synthesis and abundance of VGLUT2 in local spinal cord neurons. A
diffuse VGLUT2 mRNA signal was observed in laminae II-III, even though it always
appeared associated with neuronal somata. It has been suggested that a similar type of signal
in the rat spinal cord related to the small size and possibly low transcript levels in these
neurons (Oliveira et al., 2003). The virtual absence of VGLUT2 in lamina IX, especially
noticeable at the lumbar enlargement, along with the absence of VGLUT1 (and VGLUT3),
further suggests that motoneurons and other interneurons in this lamina, and least at this
spinal segment, do not synthesize glutamate (Oliveira et al., 2003; Kullander et al., 2003;
Llewellyn-Smith et al., 2007). Whether motoneurons, which do express other glutamatergic
markers such as glutamate itself (Meister et al., 1993; Waerhaug and Ottersen, 1993) and/or
the plasma membrane-bound neuronal EAAT-3 (Meister et al., 1993), utilize a yet
undescribed VGLUT remains to be established.
The abundance and distribution of VGLUT2 in spinal cord neurons in the rat (Oliveira et al.,
2003; Todd et al., 2003; Kullander et al., 2003; Landry et al., 2004; Llewellyn-Smith et al.,
2007) and mouse (present study) suggests its expression in both interneurons (Oliveira et al.,
2003; Todd et al., 2003) and projection neurons. In fact, immunohistochemical analysis of
nerve terminals produced by interneurons in the spinal cord of rat demonstrated that many of
such terminals, which express somatostatin, neurotensin, substance P and/or enkephalin,
also express VGLUT2 (Todd et al., 2003). More definitive evidence is provided by
electrophysiology studies in the rat, where functionally identified excitatory interneurons
show presence of VGLUT2-Li (Maxwell et al., 2007; Schneider et al., 2007; Yasaka et al.,
2010). Our data supports the existence of several populations of excitatory glutamatergic
spinal interneurons utilizing VGLUT2, also in the mouse. In addition, studies showing
VGLUT2-Li in the large lemniscal and spinothalamic terminals to the ventral posterior
thalamic nuclei in the rat (Graziano et al., 2008), also suggest that at least a number of
neurons expressing VGLUT2 mRNA in the rat and mouse dorsal horn are projection
neurons. Moreover, coexpression of both VGLUT1- and VGLUT2-Lis in mossy fibers in the
cerebellum (see Gebre et al., 2012) suggests that Clarke’s nucleus also expresses VGLUT2.
The presence of VGLUT2 in numerous spinal cord neurons also supports the concept that
the abundant VGLUT2-Li normally observed in the gray matter of the spinal cord reported
in rat (Oliveira et al., 2003; Li et al., 2003a; Alvarez et al., 2004; Landry et al., 2004) and
mouse (Brumovsky et al., 2007) strongly depends on local sources. In support, dorsal
rhizotomy fails to reduce VGLUT2-Li in the rodent spinal cord (Oliveira et al., 2003;
Alvarez et al., 2004; Brumovsky et al., 2007), revealing only a minor contribution by DRG
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neurons (Todd et al., 2003; Alvarez et al., 2004). However, dorsal root ligation results in a
modest accumulation of VGLUT2-Li (DRG side) in the mouse, implying low quantities of
VGLUT2 being transported from the DRGs to the spinal cord (Brumovsky et al., 2007).
Moreover, Todd et al. (2003) reported variable intensities (from low to high) of VGLUT2-Li
in myelinated and unmyelinated primary afferent fibers. Therefore, a modest contribution of
VGLUT2 by DRG neurons, overlapped by a strong local presence in spinal interneurons and
projection neurons, may explain the apparent lack of change in VGLUT2-Li after dorsal
rhizotomy. A similar hypothesis has been proposed for the expression of the neuropeptide
tyrosine Y1 receptor in rat primary afferents (Brumovsky et al., 2002).
Gras et al. (2002) were the first to report, based on RT-PCR of tissue sample explants, the
presence of VGLUT3 mRNA in the rat dorsal and ventral horns of the spinal cord. However,
later studies showing lack of mRNA in situ hybridization signal of this transporter (Oliveira
et al., 2003) suggested that VGLUT3 was not expressed by local spinal cord neurons in the
rat. Such an assumption was strengthened by studies in transgenic mice, where VGLUT3-
EGFP was virtually absent in the spinal cord (Seal et al., 2009). In contrast, in another study
in adult rats, using non-radioactive riboprobe in situ hybridization, a very modest expression
of VGLUT3 was reported in deep laminae of the dorsal horn, and in the ventral horn (Landry
et al., 2004). In the present study in adult mice, VGLUT3 appeared as the least expressed
transporter, and only weakly detected in some neurons in laminae III-IV of the dorsal horn.
Interestingly, a recently published study demonstrates presence of VGLUT3 transcript in
what appears to be two populations, one in the superficial and another in the deep layers of
the dorsal horn of neonatal mice (Lou et al., 2013). It is possible that VGLUT3-expressing
neurons in the superficial dorsal horn lost the capacity to synthesize the transporter in adult
life, and only a limited number of neurons in deeper laminae remained capable of producing
detectable quantities of the transporter, as shown here. It is not clear, if VGLUT3 transcript
in these neurons is translated into protein. However, a virtual absence of VGLUT3-EGFP-IR
neurons was reported in transgenic mice (Seal et al., 2009). In such case, the moderate
VGLUT3-EGFP-Li detected in the superficial dorsal horn would be mostly dependent on the
contribution from DRG neurons; in fact, dorsal rhizotomy completely abolished the
presence of VGLUT3-EGFP-Li (Seal et al., 2009). However, it should be noted that nerve
fibers exhibiting VGLUT3-Li have also been described in the sympathetic intermediolateral
column, although their coexpression with serotonin supports a supraspinal origin (see
Oliveira et al., 2003).
Effects of peripheral nerve injury and hindpaw inflammation on VGLUT transcripts
VGLUTs, in particular VGLUT2 (Moechars et al., 2006; Leo et al., 2009; Lagerström et al.,
2010; Liu et al., 2010; Scherrer et al., 2010) and VGLUT3 (Seal et al., 2009; Yang et al.,
2012; Lou et al., 2013), have been proposed as relevant to pain mechanisms during
conditions such as peripheral nerve injury or tissue inflammation. Both types of injuries
result in the down-regulation and up-regulation of numerous molecules involved in a variety
of functions in DRG and sympathetic ganglia neurons, as well as motoneurons in the spinal
cord (Costigan et al., 2002; Xiao et al., 2002; Ren et al., 2005; Anseloni et al., 2005; Hökfelt
et al., 2007; Navarro et al., 2007; Hökfelt et al., 2013). Accordingly, the protein expression
of VGLUTs appears to be challenged by peripheral nerve injury. Hughes et al., (2004)
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demonstrated that axotomy of the sciatic nerve in rat induces depletion of VGLUT1 protein
in low-threshold cutaneous and muscle mechanoreceptors terminating in the dorsal and
ventral horns. Such depletion most likely results from the dramatic decrease in VGLUT1-Li
observed after axotomy of the sciatic nerve in large and medium-sized DRG neurons, as
shown in mouse (Brumovsky et al., 2007). Axotomy of the sciatic nerve in the mouse also
results in a moderate reduction in the number of VGLUT2-IR DRG neurons, although an
increase of VGLUT2-Li was also detected in a subpopulation of small DRG neurons
(Brumovsky et al., 2007). However, and in contrast to VGLUT1, these changes do
apparently not translate into the expected decreases/increases in VGLUT2-Li at the lumbar
segments of the spinal cord, probably due to a modest centrifugal transport through central
projections and dense local VGLUT2 systems (see above) (Brumovsky et al., 2007).
Because changes in transcriptional regulation of VGLUTs induced by different pathological
stimuli had been demonstrated in neurons in the CNS (see Smith et al., 2001; Kawasaki et
al., 2005; Kawano et al., 2006), and based on the protein changes described above (Hughes
et al., 2004; Brumovsky et al., 2007), we hypothesized that VGLUT transcripts would also
exhibit alterations after peripheral nerve injury. However, here we show that the number of
VGLUT1- or VGLUT2 mRNA-positive DRG (and spinal cord) neurons were unchanged in
mice 7 days after sciatic nerve axotomy. Moreover, only a modest down-regulation in the
number of VGLUT3 mRNA positive DRG neurons was observed after axotomy. Differences
in the techniques (in situ hybridization vs. immunohistochemistry) and mouse strains (BalbC
vs. NMRI mice) between studies could explain the discrepancy.
As described in previous sections, neonatal mice express VGLUT3 in medium-sized and
large DRG neurons, and this disappears during adulthood (Lou et al., 2013). Because other
molecules, for example the neuropeptide galanin also exhibit abundant prenatal expression
that is lost during adulthood but evoked by peripheral nerve injury (Xu et al., 1996), an
increase in the number of VGLUT3 mRNA-expressing large and medium-sized DRG NPs
could have been expected. However, besides the down-regulation in small DRG neurons
described in the present study, no evidence of VGLUT3 transcript up-regulation was
obtained.
Despite the modest changes reported here in VGLUTs transcripts after peripheral nerve
injury, the downregulation of VGLUT1- (Hughes et al., 2004) and VGLUT2-Lis
(Brumovsky et al., 2007) and VGLUT3 mRNAs in DRG neurons (present study) may still
reflect cellular efforts to counteract excess excitability at the spinal cord level, or even a
protection mechanism against toxic glutamate levels in the extracellular space. In fact, in
Drosophila, the overexpression of VGLUTs has been associated with increased spontaneous
glutamate release, behavioral defects and premature death (Daniels et al., 2011).
Alternatively, it could be speculated that, despite protein down-regulation of VGLUT1 and
VGLUT2 protein after injury, DRG neurons maintain their transcription and contribute to
the increased excitatory mechanisms at the spinal level. Such a scenario could be compatible
with protein depletion at the neuronal cell body due to an increased centrifugal transport of
synaptic vesicles containing VGLUTs, and use at peripheral and central terminals
(Brumovsky et al., 2007). In support of this hypothesis, it has been observed that axotomy of
the sciatic nerve in rats results in a reduction in the number of synaptic vesicles in the central
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terminals of axotomized primary afferents (Kapadia and LaMotte, 1987), including
peptidergic ones (Zhang et al., 1995), suggesting increased clear synaptic vesicles (also
containing VGLUTs) turnover.
Several lines of evidence support a role for glutamate in the periphery and during
inflammatory processes. Thus, electrical stimulation of sciatic nerve A and/or C fibers,
peripheral formalin and capsaicin treatments increase glutamate in the hindpaw extracellular
space, likely due to its release by peripheral nerve endings arising in DRG somata (Agrawal
and Evans, 1986; Evans et al., 1987; deGroot et al., 2000). Accordingly, exogenously
administered glutamate activates peripheral glutamate receptors, resulting in depolarization
of primary afferent C fibers and induction of pain-related behavior (Carlton et al., 1995;
Jackson et al., 1995; deGroot et al., 2000; Tian et al., 2005). Interestingly, glutaminase, the
enzyme catalyzing the synthesis of glutamate from the precursor glutamine, is up-regulated
in rat DRG neurons during hindpaw inflammation (Hoffman and Miller, 2010; Miller et al.,
2012). Therefore, it seemed plausible that tissue inflammation could drive changes in the
transcript expression of VGLUTs. However, here we show that inflammation of the
hindpaw also fails to induce detectable changes in the number of neurons expressing
VGLUT1, VGLUT2 or VGLUT3 mRNAs, either in DRGs or the spinal cord. It remains to
be established if the protein expression of VGLUTs is altered by hindpaw inflammation.
The lack of changes described above after peripheral nerve injury (with the exception of the
modest down-regulation of VGLUT3 in DRG neurons) or inflammation may also reflect the
essential role of synaptic vesicle/protein regulation and trafficking at the glutamatergic
synapse (see Santos et al., 2009). An active and tight regulation of presynaptic vesicle and
transmitter recycling occurs at the level of the synaptic cleft, to counteract depletion in
situations of high activity (see Edwards, 2007; Chaudhry et al., 2008; Santos et al., 2009).
Moreover, glutamate concentration, crucial in defining intravesicular glutamate content (see
Edwards, 2007; Chaudhry et al., 2008), is 2 to 3 times higher in the terminals than in the cell
body (see Featherstone, 2010). In support, the intraplantar inhibition of glutaminase reduces
the inflammation-induced hindpaw edema and cFos expression in laminae I-II of the dorsal
horn of rats, resulting in long-lasting analgesia (Hoffman and Miller, 2010). Altogether, it is
possible that nerve injury and/or inflammation resulted in changes in the expression of
synaptic vesicles, associated proteins (including VGLUTs) and neuronal glutamatergic
machinery in general, contributing to a finer ‘tuning’ of pain mechanisms at the synaptic
rather than at the cell body level.
In conclusion, these data further extend earlier (Tong et al., 2001; Varoqui et al., 2002;
Oliveira et al., 2003; Todd et al., 2003; Kullander et al., 2003; Alvarez et al., 2004; Hwang
et al., 2004; Landry et al., 2004; Morris et al., 2005; Persson et al., 2006; Brumovsky et al.,
2007; Llewellyn-Smith et al., 2007) and more recent studies (Seal et al., 2009; Lou et al.,
2013) on the expression of VGLUTs in non-visceral DRGs and the spinal cord, and reveal a
very modest reaction to injury, only for VGLUT3 transcript and after peripheral nerve
axotomy. Further research will be necessary to better understand the transcriptional and
translational regulation of VGLUTs and their impact in normal as well as pathological
conditions.
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Mouse DRG neurons express VGLUTs mRNA in different proportions and size
distributions
Many VGLUT2 mRNA-positive neurons are found at most laminae and spinal cord
levels
VGLUT1 and VGLUT3 transcripts show a discrete expression in the mouse spinal cord
Only VGLUT3 mRNA downregulation is observed after sciatic nerve axotomy
MALET et al. Page 21














VGLUTs transcripts are abundantly expressed in L4-5 DRGs. Dark- (A, D, G) and bright-
field (B, C, E, F, H, I) photomicrographs of sections of contralateral DRGs from sham mice,
hybridized with ‘antisense’ (A, B, D, E, G, H) and ‘sense’ (C, F, I) riboprobes against
VGLUT1 (A-C), VGLUT2 (D-F) and VGLUT3 (G-I). Boxes in A, D, G are shown at higher
magnification in B, E, H. (A, B) Many VGLUT1 mRNA-positive DRG NPs are observed
(A), and these are usually large and medium-sized (white double arrowheads in D). Some
small to medium-sized VGLUT1 mRNA-positive NPs are also found (black double
arrowheads in D). Asterisks in (A) and arrowheads in (D) show NPs negative for VGLUT1.
(B, E) Abundant VGLUT2 mRNA-positive NPs are present in DRGs (B). Many exhibit
small size (black double arrowheads in E), although several others are large and medium-
sized (white double arrowheads in E). Asterisks in (B) and arrowheads in (E) show NPs
negative for VGLUT2. (C, F). A modest number of VGLUT3 mRNA-positive NPs is
detected (C), usually being of small size (white double arrowheads in F). Arrowheads in (F)
show NPs negative for VGLUT3. (G-I) Hybridization with the control ‘sense’ riboprobe for
each VGLUT revealed no specific signal for VGLUT1, VGLUT2, or VGLUT3 (G, H, I,
respectively). However, a higher background was noticed in sections hybridized with both
antisense (C, H) and sense (I) VGLUT3 riboprobes, likely due to the longer exposure times
necessary for VGLUT3. Scale bars = 100 μm (C=A, D; I=B, C, E, F, H).
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VGLUTs transcripts exhibit different size-distribution patterns. Graphs showing the size
distribution of VGLUT1- (A), VGLUT2- (B) or VGLUT3 (C) mRNA-positive DRG NPs.
(A) Most VGLUT1 mRNA-positive NPs are large to medium-sized. (B) VGLUT2 mRNA-
positive NPs show a widespread distribution, including large, medium-sized and small NPs.
(C) Most VGLUT3 mRNA-positive NPs are small to medium-sized.
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VGLUTs transcripts exhibit differential expressions across laminae and spinal cord levels.
Dark-field photomicrographs of transverse sections of the spinal cord of sham-Axo mice at
thoracolumbar (A, E, I, D), lumbar (B, F, J, H) and lumbosacral (C, G, K, L) segments,
hybridized with antisense (A-C, E-G, I,K) and sense (D, H, L) riboprobes against VGLUT1
(A-D), VGLUT2 (E-H), or VGLUT3 (I-L). (A-C) A small number of VGLUT1 mRNA-
positive neurons is detected in the dorsomedial aspect of the intermediate dorsal horn at
thoracolumbar segments, possibly corresponding to the dorsal nucleus of Clarke
(arrowheads in A). Occasional VGLUT1 mRNA-positive neurons are also detected in the
medial part of the deep dorsal horn at lumbar segments (arrowheads in B). No neurons are
detected at lumbosacral segments (C). (E-H) Abundant VGLUT2 mRNA-positive neurons
are observed in the dorsal and ventral horns, and in area X at all analyzed spinal cord
segments, with the exception of lamina IX, where virtually no VGLUT2 mRNA-positive
neurons are detected (asterisks in F). (I-K) Only few weakly labeled VGLUT3 mRNA-
positive neurons were detected in the spinal cord, and only in laminae III-IV of the dorsal
horn, at all analyzed segments (arrowheads). (J-L) Hybridization with the control ‘sense’
riboprobe for each VGLUT resulted in no signal for VGLUT1, VGLUT2, or VGLUT3 (D,
H, L, respectively). TL, thoracolumbar; L, lumbar; LS, lumbosacral. Scale bar: 100 μm (A-
L).
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VGLUT1 mRNA is selectively expressed in spinal cord areas corresponding to the dorsal
nucleus of Clarke. Dark- (A) and bright-field (B, C) photomicrographs of a section of the
thoracolumbar spinal cord of sham mice, hybridized with the ‘antisense’ riboprobe against
VGLUT1. Double arrowheads in (B) and (C) show VGLUT1 mRNA-positive neurons. (A-
C) A small group of VGLUT1 mRNA-positive neurons is detected in, probably, the dorsal
nucleus of Clarke (encircled area ‘1’ and double arrowheads in B). Additional isolated
VGLUT1 mRNA-positive neurons are also found in the intermediate aspects of laminae IV-
V of the dorsal horns (encircled area ‘2’ and double arrowheads in C). TL, thoracolumbar.
Scale bars: 100 μm (A), 50 μm (C=B).
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VGLUT2 mRNA expression in the spinal cord is widespread and appears to exclude the area
of motoneurons in the lumbar enlargement. Dark- (A) and bright-field (B-E)
photomicrographs of a section of the lumbar spinal cord of sham mice, hybridized with the
‘antisense’ riboprobe against VGLUT2. Double arrowheads in (B-E) show VGLUT2
mRNA-positive neurons. Magnified images shown in (B-E) have been taken from the areas
indicated with numbers (1-4) in (A), respectively. (A-E) Many VGLUT2 mRNA-positive
neurons are detected in the superficial (A, B) and deep (A, C) dorsal horn, area X (A, D) and
the medial aspect of the ventral horn (A, E). Note the diffuse VGLUT2 mRNA signal in the
superficial dorsal horn, always associated with somatic profiles (double arrowheads in B).
Also note the absence of VGLUT2 mRNA-positive neurons in the lateral aspect of the
ventral horn (E, white arrowheads). The dotted line in (E) represents the border between the
gray and white matter. L, lumbar. Scale bar: 100 μm (A), 50 μm (E=B-D).
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VGLUT3 mRNA is discretely expressed in some neurons in the deep dorsal horn. Dark- (A)
and bright-field (B) photomicrographs of a section of the lumbosacral spinal cord of sham
mice, hybridized with the ‘antisense’ riboprobe against VGLUT3. Double arrowheads in
(A,B) show VGLUT3 mRNA-positive neurons. (A, B) Only few VGLUT3 mRNA-positive
neurons are detected, always localized to laminae III-V of the dorsal horn (box in A; shown
at higher magnification in B). LS, lumbosacral. Scale bars: 100 μm (A), 50 μm (B).
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Axotomy of the sciatic nerve induces downregulation of VGLUT3 mRNA expression in
DRGs, leaving VGLUT1 and VGLUT2 unaffected. Dark-field photomicrographs of sections
of ipsilateral (A, C, E) and contralateral (B, D, F) DRG of mice after a 7-day axotomy of the
sciatic nerve, hybridized with ‘antisense’ riboprobes against VGLUT1 (A, B), VGLUT2 (C,
D) or VGLUT3 (E, F). Double arrowheads in (E,F) show VGLUT3 mRNA-positive NPs.
(A-F) A 7-day axotomy of the sciatic nerve does not alter the number of VGLUT1 or
VGLUT2 mRNA-positive NPs in the ipsilateral DRG, as compared to the contralateral ones
(A vs. B and C vs. D, respectively). In contrast, a decrease in the number of VGLUT3
mRNA-positive NPs was detected in ipsilateral DRG (E), as compared to the contralateral
DRG (F). Scale bar: 100 μm (F=A-E).
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Table 1
Only VGLUT3 mRNA exhibits changes after axotomy of the sciatic nerve. Percentage of DRG neurons
expressing either VGLUT1, VGLUT2 or VGLUT3 transcript, after 7-day sciatic nerve axotomy or 1- or 3-day
CFA injuries. Sham animals were also included. To provide the global percentage of neurons expressing each
VGLUT in normal conditions, the values from contralateral DRGs in sham animals were combined and
averaged accordingly.
VGLUT1 VGLUT2 VGLUT3
Ipsi Contra Ipsi Contra Ipsi Contra
7-day Axotomy 42.1 ± 0.4 (n=4) 42.5 ± 0.9 (n=4) 66.5 ± 1.7 (n=4) 69.3 ± 1.0 (n=4) 12.8 ± 0.4 (n=5)* 17.8 ± 1.6 (n=5)
Sham 40.3 ± 1.0 (n=4) 42.8 ± 1.4 (n=4) 68.9 ± 1.0 (n=4) 65.7 ± 1.8 (n=4) 15.1 ± 0.5 (n=5) 15.7 ± 1.1 (n=5)
1-day Inflammation 52.2 ± 0.6 (n=3) 51.5 ± 1.6 (n=3) 78.7 ± 1.6 (n=3) 76.1 ± 0.8 (n=3) 16.1 ± 0.9 (n=5) 14.4 ± 0.3 (n=5)
Sham 51.3 ± 2.4 (n=3) 52.8 ± 0.8 (n=3) 78.9 ± 1.7 (n=3) 76.6 ± 2.0 (n=3) 14.0 ± 0.7 (n=5) 17.6 ± 1.4 (n=5)
3-day Inflammation 38.4 ± 0.8 (n=4) 41.8 ± 1.8 (n=4) 64.9 ± 1.8 (n=4) 66.0 ± 2.5 (n=4) 16.4 ± 0.9 (n=5) 17.6 ± 1.3 (n=5)
Sham 41.0 ± 1.2 (n=3) 38.8 ± 0.9 (n=3) 62.3 ± 3.2 (n=3) 64.7 ± 1.8 (n=3) 16.1 ± 1.2 (n=5) 18.4 ± 0.6 (n=5)
Global Percentage 44.7 ± 4.2 (n=10) 69.1 ± 3.7 (n=10) 17.1 ± 0.7 (n=15)
Values are expressed as mean ± SEM.
*(P<0.05) when comparing contra- vs. ipsilateral DRGs after a 7-day axotomy.
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